Global Cyclic Peptides Market Growth 2026-2032
The global Cyclic Peptides market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Customized cyclic peptides refer to cyclic peptides that are designed, synthesized, and optimized according to specific needs and application purposes, and different methods are used according to different functional requirements. Customized cyclization strategies include single/double/triple disulfide bonds, click cyclization, lactone, lactam, RCM, etc. The cyclization positions can include head-tail, head-side chain, side chain-side chain, and side chain-tail.
United States market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cyclic Peptides players cover JPT Peptide Technologies GmbH, BACHEM, CPC Scientific, Pepscan, United States Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cyclic Peptides Industry Forecast” looks at past sales and reviews total world Cyclic Peptides sales in 2025, providing a comprehensive analysis by region and market sector of projected Cyclic Peptides sales for 2026 through 2032. With Cyclic Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclic Peptides industry.
This Insight Report provides a comprehensive analysis of the global Cyclic Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclic Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclic Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclic Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclic Peptides.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclic Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Customized cyclic peptides refer to cyclic peptides that are designed, synthesized, and optimized according to specific needs and application purposes, and different methods are used according to different functional requirements. Customized cyclization strategies include single/double/triple disulfide bonds, click cyclization, lactone, lactam, RCM, etc. The cyclization positions can include head-tail, head-side chain, side chain-side chain, and side chain-tail.
United States market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cyclic Peptides is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cyclic Peptides players cover JPT Peptide Technologies GmbH, BACHEM, CPC Scientific, Pepscan, United States Biological, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Cyclic Peptides Industry Forecast” looks at past sales and reviews total world Cyclic Peptides sales in 2025, providing a comprehensive analysis by region and market sector of projected Cyclic Peptides sales for 2026 through 2032. With Cyclic Peptides sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclic Peptides industry.
This Insight Report provides a comprehensive analysis of the global Cyclic Peptides landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclic Peptides portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclic Peptides market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclic Peptides and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclic Peptides.
This report presents a comprehensive overview, market shares, and growth opportunities of Cyclic Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Disulfide Bond Ring
- Amide Ring
- Other
- Pharmaceuticals
- Scientific Research
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- JPT Peptide Technologies GmbH
- BACHEM
- CPC Scientific
- Pepscan
- United States Biological
- RS Synthesis
- Charnwood Discovery
- Bio-Synthesis
- WuXi STA
- GL Biochem(Shanghai) Ltd
- Genscript
- Motif Biotech
- QYAOBIO
- Novopro
- Suzhou Motif Biotechnology
- What is the 10-year outlook for the global Cyclic Peptides market?
- What factors are driving Cyclic Peptides market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Cyclic Peptides market opportunities vary by end market size?
- How does Cyclic Peptides break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclic Peptides Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cyclic Peptides by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cyclic Peptides by Country/Region, 2021, 2025 & 2032
2.2 Cyclic Peptides Segment by Type
2.2.1 Disulfide Bond Ring
2.2.2 Amide Ring
2.2.3 Other
2.2.4 Cyclic Peptides Sales by Type
2.2.4.1 Global Cyclic Peptides Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cyclic Peptides Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cyclic Peptides Sale Price by Type (2021-2026)
2.3 Cyclic Peptides Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Scientific Research
2.3.3 Cyclic Peptides Sales by Application
2.3.3.1 Global Cyclic Peptides Sale Market Share by Application (2021-2026)
2.3.3.2 Global Cyclic Peptides Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Cyclic Peptides Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cyclic Peptides Breakdown Data by Company
3.1.1 Global Cyclic Peptides Annual Sales by Company (2021-2026)
3.1.2 Global Cyclic Peptides Sales Market Share by Company (2021-2026)
3.2 Global Cyclic Peptides Annual Revenue by Company (2021-2026)
3.2.1 Global Cyclic Peptides Revenue by Company (2021-2026)
3.2.2 Global Cyclic Peptides Revenue Market Share by Company (2021-2026)
3.3 Global Cyclic Peptides Sale Price by Company
3.4 Key Manufacturers Cyclic Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclic Peptides Product Location Distribution
3.4.2 Players Cyclic Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLIC PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Cyclic Peptides Market Size by Geographic Region (2021-2026)
4.1.1 Global Cyclic Peptides Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cyclic Peptides Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cyclic Peptides Market Size by Country/Region (2021-2026)
4.2.1 Global Cyclic Peptides Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cyclic Peptides Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cyclic Peptides Sales Growth
4.4 APAC Cyclic Peptides Sales Growth
4.5 Europe Cyclic Peptides Sales Growth
4.6 Middle East & Africa Cyclic Peptides Sales Growth
5 AMERICAS
5.1 Americas Cyclic Peptides Sales by Country
5.1.1 Americas Cyclic Peptides Sales by Country (2021-2026)
5.1.2 Americas Cyclic Peptides Revenue by Country (2021-2026)
5.2 Americas Cyclic Peptides Sales by Type (2021-2026)
5.3 Americas Cyclic Peptides Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclic Peptides Sales by Region
6.1.1 APAC Cyclic Peptides Sales by Region (2021-2026)
6.1.2 APAC Cyclic Peptides Revenue by Region (2021-2026)
6.2 APAC Cyclic Peptides Sales by Type (2021-2026)
6.3 APAC Cyclic Peptides Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclic Peptides by Country
7.1.1 Europe Cyclic Peptides Sales by Country (2021-2026)
7.1.2 Europe Cyclic Peptides Revenue by Country (2021-2026)
7.2 Europe Cyclic Peptides Sales by Type (2021-2026)
7.3 Europe Cyclic Peptides Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclic Peptides by Country
8.1.1 Middle East & Africa Cyclic Peptides Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cyclic Peptides Revenue by Country (2021-2026)
8.2 Middle East & Africa Cyclic Peptides Sales by Type (2021-2026)
8.3 Middle East & Africa Cyclic Peptides Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclic Peptides
10.3 Manufacturing Process Analysis of Cyclic Peptides
10.4 Industry Chain Structure of Cyclic Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclic Peptides Distributors
11.3 Cyclic Peptides Customer
12 WORLD FORECAST REVIEW FOR CYCLIC PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Cyclic Peptides Market Size Forecast by Region
12.1.1 Global Cyclic Peptides Forecast by Region (2027-2032)
12.1.2 Global Cyclic Peptides Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cyclic Peptides Forecast by Type (2027-2032)
12.7 Global Cyclic Peptides Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 JPT Peptide Technologies GmbH
13.1.1 JPT Peptide Technologies GmbH Company Information
13.1.2 JPT Peptide Technologies GmbH Cyclic Peptides Product Portfolios and Specifications
13.1.3 JPT Peptide Technologies GmbH Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 JPT Peptide Technologies GmbH Main Business Overview
13.1.5 JPT Peptide Technologies GmbH Latest Developments
13.2 BACHEM
13.2.1 BACHEM Company Information
13.2.2 BACHEM Cyclic Peptides Product Portfolios and Specifications
13.2.3 BACHEM Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BACHEM Main Business Overview
13.2.5 BACHEM Latest Developments
13.3 CPC Scientific
13.3.1 CPC Scientific Company Information
13.3.2 CPC Scientific Cyclic Peptides Product Portfolios and Specifications
13.3.3 CPC Scientific Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CPC Scientific Main Business Overview
13.3.5 CPC Scientific Latest Developments
13.4 Pepscan
13.4.1 Pepscan Company Information
13.4.2 Pepscan Cyclic Peptides Product Portfolios and Specifications
13.4.3 Pepscan Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pepscan Main Business Overview
13.4.5 Pepscan Latest Developments
13.5 United States Biological
13.5.1 United States Biological Company Information
13.5.2 United States Biological Cyclic Peptides Product Portfolios and Specifications
13.5.3 United States Biological Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 United States Biological Main Business Overview
13.5.5 United States Biological Latest Developments
13.6 RS Synthesis
13.6.1 RS Synthesis Company Information
13.6.2 RS Synthesis Cyclic Peptides Product Portfolios and Specifications
13.6.3 RS Synthesis Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 RS Synthesis Main Business Overview
13.6.5 RS Synthesis Latest Developments
13.7 Charnwood Discovery
13.7.1 Charnwood Discovery Company Information
13.7.2 Charnwood Discovery Cyclic Peptides Product Portfolios and Specifications
13.7.3 Charnwood Discovery Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Charnwood Discovery Main Business Overview
13.7.5 Charnwood Discovery Latest Developments
13.8 Bio-Synthesis
13.8.1 Bio-Synthesis Company Information
13.8.2 Bio-Synthesis Cyclic Peptides Product Portfolios and Specifications
13.8.3 Bio-Synthesis Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Synthesis Main Business Overview
13.8.5 Bio-Synthesis Latest Developments
13.9 WuXi STA
13.9.1 WuXi STA Company Information
13.9.2 WuXi STA Cyclic Peptides Product Portfolios and Specifications
13.9.3 WuXi STA Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 WuXi STA Main Business Overview
13.9.5 WuXi STA Latest Developments
13.10 GL Biochem(Shanghai) Ltd
13.10.1 GL Biochem(Shanghai) Ltd Company Information
13.10.2 GL Biochem(Shanghai) Ltd Cyclic Peptides Product Portfolios and Specifications
13.10.3 GL Biochem(Shanghai) Ltd Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 GL Biochem(Shanghai) Ltd Main Business Overview
13.10.5 GL Biochem(Shanghai) Ltd Latest Developments
13.11 Genscript
13.11.1 Genscript Company Information
13.11.2 Genscript Cyclic Peptides Product Portfolios and Specifications
13.11.3 Genscript Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Genscript Main Business Overview
13.11.5 Genscript Latest Developments
13.12 Motif Biotech
13.12.1 Motif Biotech Company Information
13.12.2 Motif Biotech Cyclic Peptides Product Portfolios and Specifications
13.12.3 Motif Biotech Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Motif Biotech Main Business Overview
13.12.5 Motif Biotech Latest Developments
13.13 QYAOBIO
13.13.1 QYAOBIO Company Information
13.13.2 QYAOBIO Cyclic Peptides Product Portfolios and Specifications
13.13.3 QYAOBIO Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 QYAOBIO Main Business Overview
13.13.5 QYAOBIO Latest Developments
13.14 Novopro
13.14.1 Novopro Company Information
13.14.2 Novopro Cyclic Peptides Product Portfolios and Specifications
13.14.3 Novopro Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Novopro Main Business Overview
13.14.5 Novopro Latest Developments
13.15 Suzhou Motif Biotechnology
13.15.1 Suzhou Motif Biotechnology Company Information
13.15.2 Suzhou Motif Biotechnology Cyclic Peptides Product Portfolios and Specifications
13.15.3 Suzhou Motif Biotechnology Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Suzhou Motif Biotechnology Main Business Overview
13.15.5 Suzhou Motif Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cyclic Peptides Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Cyclic Peptides by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Cyclic Peptides by Country/Region, 2021, 2025 & 2032
2.2 Cyclic Peptides Segment by Type
2.2.1 Disulfide Bond Ring
2.2.2 Amide Ring
2.2.3 Other
2.2.4 Cyclic Peptides Sales by Type
2.2.4.1 Global Cyclic Peptides Sales Market Share by Type (2021-2026)
2.2.4.2 Global Cyclic Peptides Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Cyclic Peptides Sale Price by Type (2021-2026)
2.3 Cyclic Peptides Segment by Application
2.3.1 Pharmaceuticals
2.3.2 Scientific Research
2.3.3 Cyclic Peptides Sales by Application
2.3.3.1 Global Cyclic Peptides Sale Market Share by Application (2021-2026)
2.3.3.2 Global Cyclic Peptides Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Cyclic Peptides Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Cyclic Peptides Breakdown Data by Company
3.1.1 Global Cyclic Peptides Annual Sales by Company (2021-2026)
3.1.2 Global Cyclic Peptides Sales Market Share by Company (2021-2026)
3.2 Global Cyclic Peptides Annual Revenue by Company (2021-2026)
3.2.1 Global Cyclic Peptides Revenue by Company (2021-2026)
3.2.2 Global Cyclic Peptides Revenue Market Share by Company (2021-2026)
3.3 Global Cyclic Peptides Sale Price by Company
3.4 Key Manufacturers Cyclic Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cyclic Peptides Product Location Distribution
3.4.2 Players Cyclic Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CYCLIC PEPTIDES BY GEOGRAPHIC REGION
4.1 World Historic Cyclic Peptides Market Size by Geographic Region (2021-2026)
4.1.1 Global Cyclic Peptides Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Cyclic Peptides Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cyclic Peptides Market Size by Country/Region (2021-2026)
4.2.1 Global Cyclic Peptides Annual Sales by Country/Region (2021-2026)
4.2.2 Global Cyclic Peptides Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cyclic Peptides Sales Growth
4.4 APAC Cyclic Peptides Sales Growth
4.5 Europe Cyclic Peptides Sales Growth
4.6 Middle East & Africa Cyclic Peptides Sales Growth
5 AMERICAS
5.1 Americas Cyclic Peptides Sales by Country
5.1.1 Americas Cyclic Peptides Sales by Country (2021-2026)
5.1.2 Americas Cyclic Peptides Revenue by Country (2021-2026)
5.2 Americas Cyclic Peptides Sales by Type (2021-2026)
5.3 Americas Cyclic Peptides Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cyclic Peptides Sales by Region
6.1.1 APAC Cyclic Peptides Sales by Region (2021-2026)
6.1.2 APAC Cyclic Peptides Revenue by Region (2021-2026)
6.2 APAC Cyclic Peptides Sales by Type (2021-2026)
6.3 APAC Cyclic Peptides Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Cyclic Peptides by Country
7.1.1 Europe Cyclic Peptides Sales by Country (2021-2026)
7.1.2 Europe Cyclic Peptides Revenue by Country (2021-2026)
7.2 Europe Cyclic Peptides Sales by Type (2021-2026)
7.3 Europe Cyclic Peptides Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cyclic Peptides by Country
8.1.1 Middle East & Africa Cyclic Peptides Sales by Country (2021-2026)
8.1.2 Middle East & Africa Cyclic Peptides Revenue by Country (2021-2026)
8.2 Middle East & Africa Cyclic Peptides Sales by Type (2021-2026)
8.3 Middle East & Africa Cyclic Peptides Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cyclic Peptides
10.3 Manufacturing Process Analysis of Cyclic Peptides
10.4 Industry Chain Structure of Cyclic Peptides
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cyclic Peptides Distributors
11.3 Cyclic Peptides Customer
12 WORLD FORECAST REVIEW FOR CYCLIC PEPTIDES BY GEOGRAPHIC REGION
12.1 Global Cyclic Peptides Market Size Forecast by Region
12.1.1 Global Cyclic Peptides Forecast by Region (2027-2032)
12.1.2 Global Cyclic Peptides Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cyclic Peptides Forecast by Type (2027-2032)
12.7 Global Cyclic Peptides Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 JPT Peptide Technologies GmbH
13.1.1 JPT Peptide Technologies GmbH Company Information
13.1.2 JPT Peptide Technologies GmbH Cyclic Peptides Product Portfolios and Specifications
13.1.3 JPT Peptide Technologies GmbH Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 JPT Peptide Technologies GmbH Main Business Overview
13.1.5 JPT Peptide Technologies GmbH Latest Developments
13.2 BACHEM
13.2.1 BACHEM Company Information
13.2.2 BACHEM Cyclic Peptides Product Portfolios and Specifications
13.2.3 BACHEM Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BACHEM Main Business Overview
13.2.5 BACHEM Latest Developments
13.3 CPC Scientific
13.3.1 CPC Scientific Company Information
13.3.2 CPC Scientific Cyclic Peptides Product Portfolios and Specifications
13.3.3 CPC Scientific Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CPC Scientific Main Business Overview
13.3.5 CPC Scientific Latest Developments
13.4 Pepscan
13.4.1 Pepscan Company Information
13.4.2 Pepscan Cyclic Peptides Product Portfolios and Specifications
13.4.3 Pepscan Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Pepscan Main Business Overview
13.4.5 Pepscan Latest Developments
13.5 United States Biological
13.5.1 United States Biological Company Information
13.5.2 United States Biological Cyclic Peptides Product Portfolios and Specifications
13.5.3 United States Biological Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 United States Biological Main Business Overview
13.5.5 United States Biological Latest Developments
13.6 RS Synthesis
13.6.1 RS Synthesis Company Information
13.6.2 RS Synthesis Cyclic Peptides Product Portfolios and Specifications
13.6.3 RS Synthesis Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 RS Synthesis Main Business Overview
13.6.5 RS Synthesis Latest Developments
13.7 Charnwood Discovery
13.7.1 Charnwood Discovery Company Information
13.7.2 Charnwood Discovery Cyclic Peptides Product Portfolios and Specifications
13.7.3 Charnwood Discovery Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Charnwood Discovery Main Business Overview
13.7.5 Charnwood Discovery Latest Developments
13.8 Bio-Synthesis
13.8.1 Bio-Synthesis Company Information
13.8.2 Bio-Synthesis Cyclic Peptides Product Portfolios and Specifications
13.8.3 Bio-Synthesis Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Synthesis Main Business Overview
13.8.5 Bio-Synthesis Latest Developments
13.9 WuXi STA
13.9.1 WuXi STA Company Information
13.9.2 WuXi STA Cyclic Peptides Product Portfolios and Specifications
13.9.3 WuXi STA Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 WuXi STA Main Business Overview
13.9.5 WuXi STA Latest Developments
13.10 GL Biochem(Shanghai) Ltd
13.10.1 GL Biochem(Shanghai) Ltd Company Information
13.10.2 GL Biochem(Shanghai) Ltd Cyclic Peptides Product Portfolios and Specifications
13.10.3 GL Biochem(Shanghai) Ltd Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 GL Biochem(Shanghai) Ltd Main Business Overview
13.10.5 GL Biochem(Shanghai) Ltd Latest Developments
13.11 Genscript
13.11.1 Genscript Company Information
13.11.2 Genscript Cyclic Peptides Product Portfolios and Specifications
13.11.3 Genscript Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Genscript Main Business Overview
13.11.5 Genscript Latest Developments
13.12 Motif Biotech
13.12.1 Motif Biotech Company Information
13.12.2 Motif Biotech Cyclic Peptides Product Portfolios and Specifications
13.12.3 Motif Biotech Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Motif Biotech Main Business Overview
13.12.5 Motif Biotech Latest Developments
13.13 QYAOBIO
13.13.1 QYAOBIO Company Information
13.13.2 QYAOBIO Cyclic Peptides Product Portfolios and Specifications
13.13.3 QYAOBIO Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 QYAOBIO Main Business Overview
13.13.5 QYAOBIO Latest Developments
13.14 Novopro
13.14.1 Novopro Company Information
13.14.2 Novopro Cyclic Peptides Product Portfolios and Specifications
13.14.3 Novopro Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Novopro Main Business Overview
13.14.5 Novopro Latest Developments
13.15 Suzhou Motif Biotechnology
13.15.1 Suzhou Motif Biotechnology Company Information
13.15.2 Suzhou Motif Biotechnology Cyclic Peptides Product Portfolios and Specifications
13.15.3 Suzhou Motif Biotechnology Cyclic Peptides Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Suzhou Motif Biotechnology Main Business Overview
13.15.5 Suzhou Motif Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cyclic Peptides Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cyclic Peptides Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Disulfide Bond Ring
Table 4. Major Players of Amide Ring
Table 5. Major Players of Other
Table 6. Global Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 7. Global Cyclic Peptides Sales Market Share by Type (2021-2026)
Table 8. Global Cyclic Peptides Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cyclic Peptides Revenue Market Share by Type (2021-2026)
Table 10. Global Cyclic Peptides Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Cyclic Peptides Sale by Application (2021-2026) & (kg)
Table 12. Global Cyclic Peptides Sale Market Share by Application (2021-2026)
Table 13. Global Cyclic Peptides Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cyclic Peptides Revenue Market Share by Application (2021-2026)
Table 15. Global Cyclic Peptides Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Cyclic Peptides Sales by Company (2021-2026) & (kg)
Table 17. Global Cyclic Peptides Sales Market Share by Company (2021-2026)
Table 18. Global Cyclic Peptides Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cyclic Peptides Revenue Market Share by Company (2021-2026)
Table 20. Global Cyclic Peptides Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Cyclic Peptides Producing Area Distribution and Sales Area
Table 22. Players Cyclic Peptides Products Offered
Table 23. Cyclic Peptides Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cyclic Peptides Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global Cyclic Peptides Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cyclic Peptides Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cyclic Peptides Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cyclic Peptides Sales by Country/Region (2021-2026) & (kg)
Table 31. Global Cyclic Peptides Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cyclic Peptides Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cyclic Peptides Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 35. Americas Cyclic Peptides Sales Market Share by Country (2021-2026)
Table 36. Americas Cyclic Peptides Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 38. Americas Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 39. APAC Cyclic Peptides Sales by Region (2021-2026) & (kg)
Table 40. APAC Cyclic Peptides Sales Market Share by Region (2021-2026)
Table 41. APAC Cyclic Peptides Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 43. APAC Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 44. Europe Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 45. Europe Cyclic Peptides Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 47. Europe Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa Cyclic Peptides Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Cyclic Peptides
Table 53. Key Market Challenges & Risks of Cyclic Peptides
Table 54. Key Industry Trends of Cyclic Peptides
Table 55. Cyclic Peptides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cyclic Peptides Distributors List
Table 58. Cyclic Peptides Customer List
Table 59. Global Cyclic Peptides Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global Cyclic Peptides Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas Cyclic Peptides Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cyclic Peptides Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC Cyclic Peptides Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe Cyclic Peptides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa Cyclic Peptides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cyclic Peptides Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global Cyclic Peptides Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cyclic Peptides Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global Cyclic Peptides Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. JPT Peptide Technologies GmbH Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 74. JPT Peptide Technologies GmbH Cyclic Peptides Product Portfolios and Specifications
Table 75. JPT Peptide Technologies GmbH Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. JPT Peptide Technologies GmbH Main Business
Table 77. JPT Peptide Technologies GmbH Latest Developments
Table 78. BACHEM Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. BACHEM Cyclic Peptides Product Portfolios and Specifications
Table 80. BACHEM Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. BACHEM Main Business
Table 82. BACHEM Latest Developments
Table 83. CPC Scientific Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. CPC Scientific Cyclic Peptides Product Portfolios and Specifications
Table 85. CPC Scientific Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. CPC Scientific Main Business
Table 87. CPC Scientific Latest Developments
Table 88. Pepscan Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Pepscan Cyclic Peptides Product Portfolios and Specifications
Table 90. Pepscan Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. Pepscan Main Business
Table 92. Pepscan Latest Developments
Table 93. United States Biological Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. United States Biological Cyclic Peptides Product Portfolios and Specifications
Table 95. United States Biological Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. United States Biological Main Business
Table 97. United States Biological Latest Developments
Table 98. RS Synthesis Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. RS Synthesis Cyclic Peptides Product Portfolios and Specifications
Table 100. RS Synthesis Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. RS Synthesis Main Business
Table 102. RS Synthesis Latest Developments
Table 103. Charnwood Discovery Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. Charnwood Discovery Cyclic Peptides Product Portfolios and Specifications
Table 105. Charnwood Discovery Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. Charnwood Discovery Main Business
Table 107. Charnwood Discovery Latest Developments
Table 108. Bio-Synthesis Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. Bio-Synthesis Cyclic Peptides Product Portfolios and Specifications
Table 110. Bio-Synthesis Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Bio-Synthesis Main Business
Table 112. Bio-Synthesis Latest Developments
Table 113. WuXi STA Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. WuXi STA Cyclic Peptides Product Portfolios and Specifications
Table 115. WuXi STA Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. WuXi STA Main Business
Table 117. WuXi STA Latest Developments
Table 118. GL Biochem(Shanghai) Ltd Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. GL Biochem(Shanghai) Ltd Cyclic Peptides Product Portfolios and Specifications
Table 120. GL Biochem(Shanghai) Ltd Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. GL Biochem(Shanghai) Ltd Main Business
Table 122. GL Biochem(Shanghai) Ltd Latest Developments
Table 123. Genscript Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. Genscript Cyclic Peptides Product Portfolios and Specifications
Table 125. Genscript Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 126. Genscript Main Business
Table 127. Genscript Latest Developments
Table 128. Motif Biotech Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. Motif Biotech Cyclic Peptides Product Portfolios and Specifications
Table 130. Motif Biotech Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 131. Motif Biotech Main Business
Table 132. Motif Biotech Latest Developments
Table 133. QYAOBIO Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. QYAOBIO Cyclic Peptides Product Portfolios and Specifications
Table 135. QYAOBIO Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 136. QYAOBIO Main Business
Table 137. QYAOBIO Latest Developments
Table 138. Novopro Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 139. Novopro Cyclic Peptides Product Portfolios and Specifications
Table 140. Novopro Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 141. Novopro Main Business
Table 142. Novopro Latest Developments
Table 143. Suzhou Motif Biotechnology Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 144. Suzhou Motif Biotechnology Cyclic Peptides Product Portfolios and Specifications
Table 145. Suzhou Motif Biotechnology Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 146. Suzhou Motif Biotechnology Main Business
Table 147. Suzhou Motif Biotechnology Latest Developments
Table 1. Cyclic Peptides Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cyclic Peptides Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Disulfide Bond Ring
Table 4. Major Players of Amide Ring
Table 5. Major Players of Other
Table 6. Global Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 7. Global Cyclic Peptides Sales Market Share by Type (2021-2026)
Table 8. Global Cyclic Peptides Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cyclic Peptides Revenue Market Share by Type (2021-2026)
Table 10. Global Cyclic Peptides Sale Price by Type (2021-2026) & (US$/g)
Table 11. Global Cyclic Peptides Sale by Application (2021-2026) & (kg)
Table 12. Global Cyclic Peptides Sale Market Share by Application (2021-2026)
Table 13. Global Cyclic Peptides Revenue by Application (2021-2026) & ($ million)
Table 14. Global Cyclic Peptides Revenue Market Share by Application (2021-2026)
Table 15. Global Cyclic Peptides Sale Price by Application (2021-2026) & (US$/g)
Table 16. Global Cyclic Peptides Sales by Company (2021-2026) & (kg)
Table 17. Global Cyclic Peptides Sales Market Share by Company (2021-2026)
Table 18. Global Cyclic Peptides Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Cyclic Peptides Revenue Market Share by Company (2021-2026)
Table 20. Global Cyclic Peptides Sale Price by Company (2021-2026) & (US$/g)
Table 21. Key Manufacturers Cyclic Peptides Producing Area Distribution and Sales Area
Table 22. Players Cyclic Peptides Products Offered
Table 23. Cyclic Peptides Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Cyclic Peptides Sales by Geographic Region (2021-2026) & (kg)
Table 27. Global Cyclic Peptides Sales Market Share Geographic Region (2021-2026)
Table 28. Global Cyclic Peptides Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Cyclic Peptides Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Cyclic Peptides Sales by Country/Region (2021-2026) & (kg)
Table 31. Global Cyclic Peptides Sales Market Share by Country/Region (2021-2026)
Table 32. Global Cyclic Peptides Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Cyclic Peptides Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 35. Americas Cyclic Peptides Sales Market Share by Country (2021-2026)
Table 36. Americas Cyclic Peptides Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 38. Americas Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 39. APAC Cyclic Peptides Sales by Region (2021-2026) & (kg)
Table 40. APAC Cyclic Peptides Sales Market Share by Region (2021-2026)
Table 41. APAC Cyclic Peptides Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 43. APAC Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 44. Europe Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 45. Europe Cyclic Peptides Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 47. Europe Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 48. Middle East & Africa Cyclic Peptides Sales by Country (2021-2026) & (kg)
Table 49. Middle East & Africa Cyclic Peptides Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Cyclic Peptides Sales by Type (2021-2026) & (kg)
Table 51. Middle East & Africa Cyclic Peptides Sales by Application (2021-2026) & (kg)
Table 52. Key Market Drivers & Growth Opportunities of Cyclic Peptides
Table 53. Key Market Challenges & Risks of Cyclic Peptides
Table 54. Key Industry Trends of Cyclic Peptides
Table 55. Cyclic Peptides Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Cyclic Peptides Distributors List
Table 58. Cyclic Peptides Customer List
Table 59. Global Cyclic Peptides Sales Forecast by Region (2027-2032) & (kg)
Table 60. Global Cyclic Peptides Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 62. Americas Cyclic Peptides Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Cyclic Peptides Sales Forecast by Region (2027-2032) & (kg)
Table 64. APAC Cyclic Peptides Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 66. Europe Cyclic Peptides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Cyclic Peptides Sales Forecast by Country (2027-2032) & (kg)
Table 68. Middle East & Africa Cyclic Peptides Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Cyclic Peptides Sales Forecast by Type (2027-2032) & (kg)
Table 70. Global Cyclic Peptides Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Cyclic Peptides Sales Forecast by Application (2027-2032) & (kg)
Table 72. Global Cyclic Peptides Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. JPT Peptide Technologies GmbH Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 74. JPT Peptide Technologies GmbH Cyclic Peptides Product Portfolios and Specifications
Table 75. JPT Peptide Technologies GmbH Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 76. JPT Peptide Technologies GmbH Main Business
Table 77. JPT Peptide Technologies GmbH Latest Developments
Table 78. BACHEM Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 79. BACHEM Cyclic Peptides Product Portfolios and Specifications
Table 80. BACHEM Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 81. BACHEM Main Business
Table 82. BACHEM Latest Developments
Table 83. CPC Scientific Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 84. CPC Scientific Cyclic Peptides Product Portfolios and Specifications
Table 85. CPC Scientific Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 86. CPC Scientific Main Business
Table 87. CPC Scientific Latest Developments
Table 88. Pepscan Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 89. Pepscan Cyclic Peptides Product Portfolios and Specifications
Table 90. Pepscan Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 91. Pepscan Main Business
Table 92. Pepscan Latest Developments
Table 93. United States Biological Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 94. United States Biological Cyclic Peptides Product Portfolios and Specifications
Table 95. United States Biological Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 96. United States Biological Main Business
Table 97. United States Biological Latest Developments
Table 98. RS Synthesis Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 99. RS Synthesis Cyclic Peptides Product Portfolios and Specifications
Table 100. RS Synthesis Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 101. RS Synthesis Main Business
Table 102. RS Synthesis Latest Developments
Table 103. Charnwood Discovery Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 104. Charnwood Discovery Cyclic Peptides Product Portfolios and Specifications
Table 105. Charnwood Discovery Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 106. Charnwood Discovery Main Business
Table 107. Charnwood Discovery Latest Developments
Table 108. Bio-Synthesis Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 109. Bio-Synthesis Cyclic Peptides Product Portfolios and Specifications
Table 110. Bio-Synthesis Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 111. Bio-Synthesis Main Business
Table 112. Bio-Synthesis Latest Developments
Table 113. WuXi STA Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 114. WuXi STA Cyclic Peptides Product Portfolios and Specifications
Table 115. WuXi STA Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 116. WuXi STA Main Business
Table 117. WuXi STA Latest Developments
Table 118. GL Biochem(Shanghai) Ltd Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 119. GL Biochem(Shanghai) Ltd Cyclic Peptides Product Portfolios and Specifications
Table 120. GL Biochem(Shanghai) Ltd Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 121. GL Biochem(Shanghai) Ltd Main Business
Table 122. GL Biochem(Shanghai) Ltd Latest Developments
Table 123. Genscript Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 124. Genscript Cyclic Peptides Product Portfolios and Specifications
Table 125. Genscript Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 126. Genscript Main Business
Table 127. Genscript Latest Developments
Table 128. Motif Biotech Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 129. Motif Biotech Cyclic Peptides Product Portfolios and Specifications
Table 130. Motif Biotech Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 131. Motif Biotech Main Business
Table 132. Motif Biotech Latest Developments
Table 133. QYAOBIO Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 134. QYAOBIO Cyclic Peptides Product Portfolios and Specifications
Table 135. QYAOBIO Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 136. QYAOBIO Main Business
Table 137. QYAOBIO Latest Developments
Table 138. Novopro Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 139. Novopro Cyclic Peptides Product Portfolios and Specifications
Table 140. Novopro Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 141. Novopro Main Business
Table 142. Novopro Latest Developments
Table 143. Suzhou Motif Biotechnology Basic Information, Cyclic Peptides Manufacturing Base, Sales Area and Its Competitors
Table 144. Suzhou Motif Biotechnology Cyclic Peptides Product Portfolios and Specifications
Table 145. Suzhou Motif Biotechnology Cyclic Peptides Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 146. Suzhou Motif Biotechnology Main Business
Table 147. Suzhou Motif Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Cyclic Peptides
Figure 2. Cyclic Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclic Peptides Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Cyclic Peptides Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cyclic Peptides Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cyclic Peptides Sales Market Share by Country/Region (2025)
Figure 10. Cyclic Peptides Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Disulfide Bond Ring
Figure 12. Product Picture of Amide Ring
Figure 13. Product Picture of Other
Figure 14. Global Cyclic Peptides Sales Market Share by Type in 2026
Figure 15. Global Cyclic Peptides Revenue Market Share by Type (2021-2026)
Figure 16. Cyclic Peptides Consumed in Pharmaceuticals
Figure 17. Global Cyclic Peptides Market: Pharmaceuticals (2021-2026) & (kg)
Figure 18. Cyclic Peptides Consumed in Scientific Research
Figure 19. Global Cyclic Peptides Market: Scientific Research (2021-2026) & (kg)
Figure 20. Global Cyclic Peptides Sale Market Share by Application (2025)
Figure 21. Global Cyclic Peptides Revenue Market Share by Application in 2026
Figure 22. Cyclic Peptides Sales by Company in 2026 (kg)
Figure 23. Global Cyclic Peptides Sales Market Share by Company in 2026
Figure 24. Cyclic Peptides Revenue by Company in 2026 ($ millions)
Figure 25. Global Cyclic Peptides Revenue Market Share by Company in 2026
Figure 26. Global Cyclic Peptides Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Cyclic Peptides Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Cyclic Peptides Sales 2021-2026 (kg)
Figure 29. Americas Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 30. APAC Cyclic Peptides Sales 2021-2026 (kg)
Figure 31. APAC Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 32. Europe Cyclic Peptides Sales 2021-2026 (kg)
Figure 33. Europe Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Cyclic Peptides Sales 2021-2026 (kg)
Figure 35. Middle East & Africa Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 36. Americas Cyclic Peptides Sales Market Share by Country in 2026
Figure 37. Americas Cyclic Peptides Revenue Market Share by Country (2021-2026)
Figure 38. Americas Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 39. Americas Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 40. United States Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Cyclic Peptides Sales Market Share by Region in 2026
Figure 45. APAC Cyclic Peptides Revenue Market Share by Region (2021-2026)
Figure 46. APAC Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 47. APAC Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 48. China Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 52. India Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Cyclic Peptides Sales Market Share by Country in 2026
Figure 56. Europe Cyclic Peptides Revenue Market Share by Country (2021-2026)
Figure 57. Europe Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 58. Europe Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 59. Germany Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 60. France Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Cyclic Peptides Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 67. Egypt Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Cyclic Peptides in 2026
Figure 73. Manufacturing Process Analysis of Cyclic Peptides
Figure 74. Industry Chain Structure of Cyclic Peptides
Figure 75. Channels of Distribution
Figure 76. Global Cyclic Peptides Sales Market Forecast by Region (2027-2032)
Figure 77. Global Cyclic Peptides Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Cyclic Peptides Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Cyclic Peptides Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Cyclic Peptides Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Cyclic Peptides Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Cyclic Peptides
Figure 2. Cyclic Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cyclic Peptides Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Cyclic Peptides Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cyclic Peptides Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cyclic Peptides Sales Market Share by Country/Region (2025)
Figure 10. Cyclic Peptides Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Disulfide Bond Ring
Figure 12. Product Picture of Amide Ring
Figure 13. Product Picture of Other
Figure 14. Global Cyclic Peptides Sales Market Share by Type in 2026
Figure 15. Global Cyclic Peptides Revenue Market Share by Type (2021-2026)
Figure 16. Cyclic Peptides Consumed in Pharmaceuticals
Figure 17. Global Cyclic Peptides Market: Pharmaceuticals (2021-2026) & (kg)
Figure 18. Cyclic Peptides Consumed in Scientific Research
Figure 19. Global Cyclic Peptides Market: Scientific Research (2021-2026) & (kg)
Figure 20. Global Cyclic Peptides Sale Market Share by Application (2025)
Figure 21. Global Cyclic Peptides Revenue Market Share by Application in 2026
Figure 22. Cyclic Peptides Sales by Company in 2026 (kg)
Figure 23. Global Cyclic Peptides Sales Market Share by Company in 2026
Figure 24. Cyclic Peptides Revenue by Company in 2026 ($ millions)
Figure 25. Global Cyclic Peptides Revenue Market Share by Company in 2026
Figure 26. Global Cyclic Peptides Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Cyclic Peptides Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Cyclic Peptides Sales 2021-2026 (kg)
Figure 29. Americas Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 30. APAC Cyclic Peptides Sales 2021-2026 (kg)
Figure 31. APAC Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 32. Europe Cyclic Peptides Sales 2021-2026 (kg)
Figure 33. Europe Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Cyclic Peptides Sales 2021-2026 (kg)
Figure 35. Middle East & Africa Cyclic Peptides Revenue 2021-2026 ($ millions)
Figure 36. Americas Cyclic Peptides Sales Market Share by Country in 2026
Figure 37. Americas Cyclic Peptides Revenue Market Share by Country (2021-2026)
Figure 38. Americas Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 39. Americas Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 40. United States Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Cyclic Peptides Sales Market Share by Region in 2026
Figure 45. APAC Cyclic Peptides Revenue Market Share by Region (2021-2026)
Figure 46. APAC Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 47. APAC Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 48. China Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 52. India Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Cyclic Peptides Sales Market Share by Country in 2026
Figure 56. Europe Cyclic Peptides Revenue Market Share by Country (2021-2026)
Figure 57. Europe Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 58. Europe Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 59. Germany Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 60. France Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Cyclic Peptides Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Cyclic Peptides Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Cyclic Peptides Sales Market Share by Application (2021-2026)
Figure 67. Egypt Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Cyclic Peptides Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Cyclic Peptides in 2026
Figure 73. Manufacturing Process Analysis of Cyclic Peptides
Figure 74. Industry Chain Structure of Cyclic Peptides
Figure 75. Channels of Distribution
Figure 76. Global Cyclic Peptides Sales Market Forecast by Region (2027-2032)
Figure 77. Global Cyclic Peptides Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Cyclic Peptides Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Cyclic Peptides Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Cyclic Peptides Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Cyclic Peptides Revenue Market Share Forecast by Application (2027-2032)
